OrthoPediatrics KIDS 深 沪
已收盘 08-01 16:00:00 美东时间
20.39
-0.330
-1.59%
华盛通- 最 高20.76
- 今 开20.50
- 成交量 16.38万股
- 最 低 19.87
- 昨 收 20.72
- 总市值 5.05亿
- 52周最高 33.14
- 市盈率 静 --
- 换手率 0.00%
- 52周最低 19.515
- 委 比 -53.04%
- 总股本 2476.90万
- 历史最高 73.91
- 量 比 1.07
- 振 幅 4.30%
- 历史最低 14.00
- 每 手 1
- 风险率 2.99%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多OrthoPediatrics Corp. Launches 3P™ Pediatric Plating Platform™ Hip System and Completes First Case
OrthoPediatrics Corp. announced the US launch of its new 3P™ Pediatric Plating Platform™ Hip System, designed to treat proximal femur fractures and deformities in children. The system features advanced implant and instrument technology, offering improved precision and fixation options for both trauma and deformity surgeries. Over 10 cases were booked shortly after the launch, with significant growth expected. The company emphasized its commitment...
08-01 12:05
Exploring Neogen's Earnings Expectations
Neogen (NASDAQ:NEOG) is gearing up to announce its quarterly earnings on Tuesda...
07-29 04:02
OrthoPediatrics Corp. to Report Second Quarter Financial Results on August 5, 2025
OrthoPediatrics Corp. has announced it will release its second quarter 2025 financial results on August 5, 2025, followed by a conference call that same day at 4:30 p.m. ET. The webcast will be available live and archived for 90 days on its Investors page. Founded in 2006, OrthoPediatrics specializes in pediatric orthopedics, offering over 80 products across trauma, scoliosis, and sports medicine. For more information, visit www.orthopediatrics.c...
07-22 20:05
OrthoPediatrics Reaches Over 600 Implants Across 300+ Pediatric Patients As Part Of Ongoing Global POISE Study
OrthoPediatrics Corp. ("OrthoPediatrics" or the "Company") (NASDAQ:KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced a significant milestone in the ongoing Global POISE
07-16 19:12
Global POISE Study Reaches Milestone of 600 Orthopedic Implants in Pediatric Patients, Advancing Research on the Safety and Efficacy of OrthoPediatrics® Products
OrthoPediatrics Corp. announced a significant milestone in its Global POISE Study, with over 600 implants being observed across 300+ pediatric patients. Launched in 2023, the multi-center, post-market study aims to assess the safety and efficacy of OrthoPediatrics' implant devices. Currently, 13 active sites in Canada, the U.S., Australia, New Zealand, and South Africa are participating. The study's insights will help refine devices for children ...
07-16 11:00
Analysts’ Top Healthcare Picks: Insulet (PODD), OrthoPediatrics (KIDS)
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts jus...
07-14 19:40
五位民营企业家代表将受邀出席国新办新闻发布会 这些企业有何特别？
7月14日，国新办官网发布预告显示，国务院新闻办公室将于2025年7月15日（星期二）下午3时举行“新征程上的奋斗者”中外记者见面会，届时将邀请民营企业家代表围...
07-14 16:51
FILA KIDS与复旦大学附属儿科医院合作，聚焦儿童骨骼发育研究
FILA KIDS与复旦大学附属儿科医院签署合作意向书，共建"儿童与青少年运动健康联合实验室"。双方将围绕儿童骨骼发育、脊柱成长等关键阶段的运动健康干预需求，开...
07-11 14:36
OrthoPediatrics Holds Annual Stockholders Meeting
OrthoPediatrics ( ($KIDS) ) just unveiled an update. On May 23, 2025, OrthoPedi...
05-28 00:48
N Is For Netflix: Streamer To Show Viewers How To Get To 'Sesame Street'
"Sesame Street" has landed a new streaming home with a partnership with Netflix announced.
05-21 00:14
